Suvretta Capital Management’s Entrada Therapeutics TRDA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-106,000	Closed	-$1.29M	–	88
2022 Q2	$1.29M	Hold	106,000	–	–	0.05%	82
2022 Q1	$995K	Hold	106,000	–	–	0.03%	79
2021 Q4	$1.82M	Buy	+106,000	New	+$1.82M	0.04%	83